Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease

The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromise...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 13; p. 826102
Main Authors Moudio, Serge, Rodin, Fredrik, Albargothy, Nazira Jamal, Karlsson, Urban, Reyes, Juan F., Hallbeck, Martin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 16.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation ex vivo . We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
AbstractList The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation ex vivo. We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation ex vivo. We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation . We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
The accumulation of proteinaceous deposits comprised largely of the alpha-synuclein protein is one of the main hallmarks of Parkinsons disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study alpha-synuclein aggregate formation ex vivo. We monitored the progressive and gradual changes induced by alpha-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as alpha-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated alpha-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of alpha-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding alpha-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation ex vivo . We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related synucleinopathies. Their progressive development coincides with site-specific phosphorylation, oxidative stress and eventually, compromised neuronal function. However, modeling protein aggregate formation in animal or in vitro models has proven notably difficult. Here, we took advantage of a preclinical organotypic brain slice culture model to study α-synuclein aggregate formation ex vivo. We monitored the progressive and gradual changes induced by α-synuclein such as cellular toxicity, autophagy activation, mitochondrial dysfunction, cellular death as well as α-synuclein modification including site-specific phosphorylation. Our results demonstrate that organotypic brain slice cultures can be cultured for long periods of time and when cultured in the presence of aggregated α-synuclein, the molecular features of PD are recapitulated. Taken together, this ex vivo model allows for detailed modeling of the molecular features of PD, thus enabling studies on the cumulative effects of α-synuclein in a complex environment. This provides a platform to screen potential disease-modifying therapeutic candidates aimed at impeding α-synuclein aggregation and/or cellular transmission. Moreover, this model provides a robust replacement for in vivo studies that do not include behavioral experiments, thus providing a way to reduce the number of animals used in an accelerated timescale.
Author Hallbeck, Martin
Reyes, Juan F.
Moudio, Serge
Karlsson, Urban
Albargothy, Nazira Jamal
Rodin, Fredrik
AuthorAffiliation 2 Department of Biomedical and Clinical Sciences, Linköping University , Linköping , Sweden
1 Department of Clinical Pathology and Department of Biomedical and Clinical Sciences, Linköping University , Linköping , Sweden
AuthorAffiliation_xml – name: 1 Department of Clinical Pathology and Department of Biomedical and Clinical Sciences, Linköping University , Linköping , Sweden
– name: 2 Department of Biomedical and Clinical Sciences, Linköping University , Linköping , Sweden
Author_xml – sequence: 1
  givenname: Serge
  surname: Moudio
  fullname: Moudio, Serge
– sequence: 2
  givenname: Fredrik
  surname: Rodin
  fullname: Rodin, Fredrik
– sequence: 3
  givenname: Nazira Jamal
  surname: Albargothy
  fullname: Albargothy, Nazira Jamal
– sequence: 4
  givenname: Urban
  surname: Karlsson
  fullname: Karlsson, Urban
– sequence: 5
  givenname: Juan F.
  surname: Reyes
  fullname: Reyes, Juan F.
– sequence: 6
  givenname: Martin
  surname: Hallbeck
  fullname: Hallbeck, Martin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35309552$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-183918$$DView record from Swedish Publication Index
BookMark eNp9ks1uEzEUhS1UREvoA7BB3sFmgn9mnPEGKUpbqCgqosDWcjzXg8tknNoeIAseihfhmXAypWpYYMny3zmffeXzGB30vgeEnlIy5byWL20PQ5gywti0ZoIS9gAdUSHKgjFZHdybH6LjGK9JblxKLvgjdMgrTmRVsSP08_TH2schAPYW__5VXG36wXTgejxv2wCtThBx8vgytLr3abN2Bl91zgBeDF3Kvog_gNFrl4Zup30LG_zOd2DyOuAz0KMo09_r8NX10ffPIz5xEXSEJ-ih1V2E49txgj6dnX5cvCkuLl-fL-YXhakITwWIGrgtlxRyObSRlebCSkJrQ2eMldYubVlLJutGa81lacFURjALltvsXPIJOh-5jdfXah3cSoeN8tqp3YYPrdIhuVy4klbMdAYzS8qyJLWWGdyQuuSN1A3bsoqRFb_Delju0U7c5_mO1rlB0ZrL3Cfo1ajP4hU0BvoUdLdn2z_p3RfV-m8qV1TVgmfAi1tA8DcDxKRWLhroOt2DH6JioqQVkYKzLH12_667S_7-dxbQUWCCjzGAvZNQoraxUrtYqW2s1Bir7Jn94zEu6eT89rmu-4_zDx9C1rw
CitedBy_id crossref_primary_10_3390_cells13030253
crossref_primary_10_1007_s00441_023_03806_1
crossref_primary_10_1016_j_ejphar_2024_176819
crossref_primary_10_1177_02611929231210777
crossref_primary_10_1016_j_gendis_2023_101130
crossref_primary_10_3390_ijms25084330
crossref_primary_10_1051_medsci_2023221
Cites_doi 10.1038/nprot.2006.228
10.1016/j.cell.2007.10.035
10.1084/jem.20182184
10.1111/j.1749-6632.2003.tb07470.x
10.1016/j.exger.2018.12.008
10.1016/j.neuroscience.2013.10.021
10.1186/1750-1326-4-9
10.1038/42166
10.1016/j.bpj.2020.01.022
10.1073/pnas.0908005106
10.1523/JNEUROSCI.09-08-02982.1989
10.1038/nprot.2006.180
10.1073/pnas.1100976108
10.2174/1568007054546108
10.1016/j.nicl.2019.101824
10.1016/j.expneurol.2013.07.012
10.1177/1073858408322839
10.1101/cshperspect.a009357
10.1007/s00401-019-02007-x
10.1038/srep31175
10.1016/0166-2236(88)90007-0
10.1016/j.neuron.2011.08.033
10.1016/j.pneurobio.2013.10.004
10.1007/s11910-018-0829-3
10.1523/JNEUROSCI.0089-14.2015
10.1016/B978-0-444-63945-5.00017-9
10.3233/JPD-150642
10.1016/j.nbd.2006.08.021
10.1038/laban.1217
10.1186/1750-1326-9-18
10.1074/jbc.M113.457408
10.1007/s00702-005-0427-9
10.3233/JPD-202026
10.1212/WNL.0000000000010084
10.1074/jbc.M110.213538
10.1111/j.1471-4159.2012.07769.x
10.1371/journal.pone.0168700
10.1073/pnas.95.11.6469
10.1186/s13024-021-00471-2
10.1073/pnas.0903691106
10.1126/science.276.5321.2045
10.1126/science.1195227
10.1056/NEJM198804073181402
10.1002/ana.10483
10.1101/cshperspect.a009399
10.1007/s00401-020-02227-6
10.1038/cdd.2015.79
10.1016/S0197-4580(02)00065-9
10.1016/0165-0270(91)90128-M
10.3791/55637
10.1038/s41598-018-21325-w
10.1186/s12974-018-1225-2
10.1007/s00401-017-1746-2
10.1073/pnas.1512876113
10.1186/s40478-014-0088-8
10.1038/npjparkd.2016.25
10.1007/s00702-013-1084-z
10.1186/s40478-019-0865-5
10.1007/s12035-012-8327-0
10.1523/JNEUROSCI.4390-09.2009
10.1155/2016/5013409
10.4161/auto.7.3.14487
10.3233/JAD-2010-091363
ContentType Journal Article
Copyright Copyright © 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck.
Copyright © 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck. 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck
Copyright_xml – notice: Copyright © 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck.
– notice: Copyright © 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck. 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck
DBID AAYXX
CITATION
NPM
7X8
5PM
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
DOA
DOI 10.3389/fneur.2022.826102
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2295
ExternalDocumentID oai_doaj_org_article_9f67a8c12f044408a9929d0843d9ad2b
oai_DiVA_org_liu_183918
PMC8925863
35309552
10_3389_fneur_2022_826102
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
E3Z
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
ID FETCH-LOGICAL-c503t-e68e3f4b1e2951d95a36f9018c17224ffbf489298daaa394fec5c62fef3f8e3b3
IEDL.DBID M48
ISSN 1664-2295
IngestDate Wed Aug 27 01:22:20 EDT 2025
Thu Aug 21 06:34:06 EDT 2025
Thu Aug 21 13:41:41 EDT 2025
Thu Jul 10 20:40:34 EDT 2025
Thu Jan 02 22:54:33 EST 2025
Tue Jul 01 04:27:50 EDT 2025
Thu Apr 24 22:59:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords PFF
Parkinson's disease
autophagy
model of CNS disease
organotypic slice cultures
α-synuclein
3R
Lewy bodies
Parkinsons disease
alpha-synuclein
Language English
License Copyright © 2022 Moudio, Rodin, Albargothy, Karlsson, Reyes and Hallbeck.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c503t-e68e3f4b1e2951d95a36f9018c17224ffbf489298daaa394fec5c62fef3f8e3b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Poul Henning Jensen, Aarhus University, Denmark; Abby Olsen, Brigham and Women's Hospital and Harvard Medical School, United States
Edited by: Lisa Fellner, University of Innsbruck, Austria
This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fneur.2022.826102
PMID 35309552
PQID 2641509632
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_9f67a8c12f044408a9929d0843d9ad2b
swepub_primary_oai_DiVA_org_liu_183918
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8925863
proquest_miscellaneous_2641509632
pubmed_primary_35309552
crossref_primary_10_3389_fneur_2022_826102
crossref_citationtrail_10_3389_fneur_2022_826102
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-02-16
PublicationDateYYYYMMDD 2022-02-16
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-16
  day: 16
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in neurology
PublicationTitleAlternate Front Neurol
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Komatsu (B52) 2007; 131
Backstrom (B62) 2020; 95
Mena (B55) 2008; 14
Mahul-Mellier (B36) 2015; 22
Volpicelli-Daley (B35) 2011; 72
Baba (B2) 1998; 152
Wei (B31) 2016; 6
Wu (B46) 2019; 116
Park (B61) 2018; 18
Simoni (B17) 2006; 1
Agholme (B30) 2010; 20
Domert (B10) 2016; 11
Luk (B14) 2009; 106
Ghavami (B57) 2014; 112
Russell (B66) 1959
Chen (B58) 2015; 35
Lynch-Day (B56) 2012; 2
Croft (B20) 2019; 216
Kish (B4) 1988; 318
Burré (B9) 2010; 329
Gähwiler (B15) 1988; 11
Magalhães (B33) 2018; 15
Desplats (B64) 2009; 106
Spillantini (B3) 1998; 95
Anglade (B41) 1997; 12
Spencer (B48) 2009; 29
Spillantini (B1) 1997; 388
Burré (B40) 2015; 5
Xie (B60) 2012; 122
Winner (B38) 2011; 108
Fares (B37) 2016; 113
Gogolla (B16) 2006; 1
Sato (B50) 2018; 8
Stoppini (B12) 1991; 37
Zhang (B32) 2016; 2016
Beal (B54) 2006; 991
Lee (B42) 2006; 113
Noraberg (B13) 2005; 4
Roux (B23) 2020; 10
Tanik (B49) 2013; 288
Loria (B21) 2017; 134
Daviaud (B19) 2014; 256
Reyes (B27) 2019; 138
Yasuda (B65) 2013; 47
Pugsley (B39) 2017
Polymeropoulos (B6) 1997; 276
La (B45) 2019; 23
Shrivastava (B22) 2020; 118
Jenner (B53) 2003; 53
Nakamura (B59) 2011; 286
Daviaud (B18) 2013; 248
Barth (B26) 2021; 16
Elfarrash (B24) 2019; 7
Volpicelli-Daley (B11) 2018; 153
Wu (B25) 2020; 140
Armstrong (B43) 2014; 121
Harris (B34) 1989; 9
Braak (B47) 2003; 24
Stefanis (B7) 2012; 2
Chu (B8) 2007; 25
Masuda-Suzukake (B28) 2014; 2
Johansen (B51) 2011; 7
Caligiore (B5) 2016; 2
Cookson (B63) 2009; 4
Jayme (B29) 1992
Overk (B44) 2014; 9
Prescott (B67) 2017; 46
References_xml – volume: 1
  start-page: 1439
  year: 2006
  ident: B17
  article-title: Preparation of organotypic hippocampal slice cultures: interface method
  publication-title: Nat Protoc.
  doi: 10.1038/nprot.2006.228
– volume: 131
  start-page: 1149
  year: 2007
  ident: B52
  article-title: Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
  publication-title: Cell.
  doi: 10.1016/j.cell.2007.10.035
– volume: 216
  start-page: 539
  year: 2019
  ident: B20
  article-title: rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologies
  publication-title: J Exp Med.
  doi: 10.1084/jem.20182184
– volume: 991
  start-page: 120
  year: 2006
  ident: B54
  article-title: Mitochondria, oxidative damage, and inflammation in Parkinson's disease
  publication-title: Ann N Y Acad Sci.
  doi: 10.1111/j.1749-6632.2003.tb07470.x
– volume: 116
  start-page: 37
  year: 2019
  ident: B46
  article-title: Alpha-synuclein is highly prone to distribution in the hippocampus and midbrain in tree shrews, and its fibrils seed Lewy body-like pathology in primary neurons
  publication-title: Exp Gerontol.
  doi: 10.1016/j.exger.2018.12.008
– volume: 256
  start-page: 10
  year: 2014
  ident: B19
  article-title: Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's disease
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2013.10.021
– volume: 4
  start-page: 9
  year: 2009
  ident: B63
  article-title: α-Synuclein and neuronal cell death
  publication-title: Mol Neurodegener.
  doi: 10.1186/1750-1326-4-9
– volume: 388
  start-page: 839
  year: 1997
  ident: B1
  article-title: α-Synuclein in Lewy bodies
  publication-title: Nature.
  doi: 10.1038/42166
– start-page: 238
  volume-title: The Principles of Humane Experimental Technique
  year: 1959
  ident: B66
– volume: 118
  start-page: 1301
  year: 2020
  ident: B22
  article-title: Differential membrane binding and seeding of distinct α-synuclein fibrillar polymorphs
  publication-title: Biophys J.
  doi: 10.1016/j.bpj.2020.01.022
– volume: 106
  start-page: 20051
  year: 2009
  ident: B14
  article-title: Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
  publication-title: Proc Nat Acad Sci USA.
  doi: 10.1073/pnas.0908005106
– volume: 9
  start-page: 2982
  year: 1989
  ident: B34
  article-title: Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics
  publication-title: J Neurosci.
  doi: 10.1523/JNEUROSCI.09-08-02982.1989
– volume: 1
  start-page: 2452
  year: 2006
  ident: B16
  article-title: Staining protocol for organotypic hippocampal slice cultures
  publication-title: Nat Protoc.
  doi: 10.1038/nprot.2006.180
– volume: 108
  start-page: 4194
  year: 2011
  ident: B38
  article-title: In vivo demonstration that α-synuclein oligomers are toxic
  publication-title: Proc Nat Acad Sci USa.
  doi: 10.1073/pnas.1100976108
– volume: 4
  start-page: 435
  year: 2005
  ident: B13
  article-title: Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair
  publication-title: Curr Drug Target CNS Neurol Disord.
  doi: 10.2174/1568007054546108
– volume: 23
  start-page: 101824
  year: 2019
  ident: B45
  article-title: Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease
  publication-title: Neuroimage.
  doi: 10.1016/j.nicl.2019.101824
– volume: 248
  start-page: 429
  year: 2013
  ident: B18
  article-title: Organotypic cultures as tools for optimizing central nervous system cell therapies
  publication-title: Exp Neurol.
  doi: 10.1016/j.expneurol.2013.07.012
– volume: 14
  start-page: 544
  year: 2008
  ident: B55
  article-title: Glial cells as players in Parkinsonism: the “good,” the “bad,” and the “mysterious” glia
  publication-title: Neuroscientist.
  doi: 10.1177/1073858408322839
– volume: 2
  start-page: a009357
  year: 2012
  ident: B56
  article-title: The role of autophagy in Parkinson's disease
  publication-title: Cold Spring Harb Perspect Med.
  doi: 10.1101/cshperspect.a009357
– volume: 138
  start-page: 23
  year: 2019
  ident: B27
  article-title: Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-019-02007-x
– volume: 6
  start-page: 31175
  year: 2016
  ident: B31
  article-title: Fetal bovine serum RNA interferes with the cell culture derived extracellular RNA
  publication-title: Sci Rep.
  doi: 10.1038/srep31175
– volume: 11
  start-page: 484
  year: 1988
  ident: B15
  article-title: Organotypic cultures of neural tissue
  publication-title: Trends Neurosci.
  doi: 10.1016/0166-2236(88)90007-0
– volume: 12
  start-page: 25
  year: 1997
  ident: B41
  article-title: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
  publication-title: Histol Histopathol.
– volume: 72
  start-page: 57
  year: 2011
  ident: B35
  article-title: Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2011.08.033
– volume: 112
  start-page: 24
  year: 2014
  ident: B57
  article-title: Autophagy and apoptosis dysfunction in neurodegenerative disorders
  publication-title: Prog Neurobiol.
  doi: 10.1016/j.pneurobio.2013.10.004
– volume: 18
  start-page: 21
  year: 2018
  ident: B61
  article-title: Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives
  publication-title: Curr Neurol Neurosci Rep.
  doi: 10.1007/s11910-018-0829-3
– volume: 35
  start-page: 890
  year: 2015
  ident: B58
  article-title: A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration
  publication-title: J Neurosci.
  doi: 10.1523/JNEUROSCI.0089-14.2015
– volume: 153
  start-page: 321
  year: 2018
  ident: B11
  article-title: Chapter 17 Prion-like propagation of pathology in Parkinson disease
  publication-title: Handb Clin Neurol.
  doi: 10.1016/B978-0-444-63945-5.00017-9
– start-page: 327
  year: 1992
  ident: B29
  article-title: Animal cell technology: basic & applied aspects
  publication-title: Proceedings of the Fourth Annual Meeting of the Japanese Association for Animal Cell Technology, Fukuoka, Japan, 13–15 November 1991.
– volume: 5
  start-page: 699
  year: 2015
  ident: B40
  article-title: The synaptic function of α-synuclein
  publication-title: J Parkinsons Dis.
  doi: 10.3233/JPD-150642
– volume: 25
  start-page: 134
  year: 2007
  ident: B8
  article-title: Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?
  publication-title: Neurobiol Dis.
  doi: 10.1016/j.nbd.2006.08.021
– volume: 46
  start-page: 152
  year: 2017
  ident: B67
  article-title: Improving quality of science through better animal welfare: the NC3Rs strategy
  publication-title: Lab Anim.
  doi: 10.1038/laban.1217
– volume: 9
  start-page: 18
  year: 2014
  ident: B44
  article-title: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
  publication-title: Mol Neurodegener.
  doi: 10.1186/1750-1326-9-18
– volume: 288
  start-page: 15194
  year: 2013
  ident: B49
  article-title: Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy*?
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M113.457408
– volume: 113
  start-page: 1435
  year: 2006
  ident: B42
  article-title: The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy
  publication-title: J Neural Transm.
  doi: 10.1007/s00702-005-0427-9
– volume: 10
  start-page: 1397
  year: 2020
  ident: B23
  article-title: Modeling α-synucleinopathy in organotypic brain slice culture with preformed α-synuclein amyloid fibrils
  publication-title: J Parkinsons Dis.
  doi: 10.3233/JPD-202026
– volume: 95
  start-page: e827
  year: 2020
  ident: B62
  article-title: NfL as a biomarker for neurodegeneration and survival in Parkinson disease
  publication-title: Neurology.
  doi: 10.1212/WNL.0000000000010084
– volume: 286
  start-page: 20710
  year: 2011
  ident: B59
  article-title: Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein α-synuclein
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M110.213538
– volume: 122
  start-page: 404
  year: 2012
  ident: B60
  article-title: Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease
  publication-title: J Neurochem.
  doi: 10.1111/j.1471-4159.2012.07769.x
– volume: 11
  start-page: e0168700
  year: 2016
  ident: B10
  article-title: Aggregated alpha-synuclein transfer efficiently between cultured human neuron-like cells and localize to lysosomes
  publication-title: PLoS ONE.
  doi: 10.1371/journal.pone.0168700
– volume: 95
  start-page: 6469
  year: 1998
  ident: B3
  article-title: α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
  publication-title: Proc Nat Acad Sci USA.
  doi: 10.1073/pnas.95.11.6469
– volume: 16
  start-page: 54
  year: 2021
  ident: B26
  article-title: Microglial inclusions and neurofilament light chain release follow neuronal alpha-synuclein lesions in long-term brain slice cultures
  publication-title: Mol Neurodegener.
  doi: 10.1186/s13024-021-00471-2
– volume: 106
  start-page: 13010
  year: 2009
  ident: B64
  article-title: Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
  publication-title: Proc Nat Acad Sci USA.
  doi: 10.1073/pnas.0903691106
– volume: 276
  start-page: 2045
  year: 1997
  ident: B6
  article-title: Mutation in the α-synuclein gene identified in families with Parkinson's disease
  publication-title: Science.
  doi: 10.1126/science.276.5321.2045
– volume: 152
  start-page: 879
  year: 1998
  ident: B2
  article-title: Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
  publication-title: Am J Pathol.
– volume: 329
  start-page: 1663
  year: 2010
  ident: B9
  publication-title: Science.
  doi: 10.1126/science.1195227
– volume: 318
  start-page: 876
  year: 1988
  ident: B4
  article-title: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease
  publication-title: N Engl J Med.
  doi: 10.1056/NEJM198804073181402
– volume: 53
  start-page: S26
  year: 2003
  ident: B53
  article-title: Oxidative stress in Parkinson's disease
  publication-title: Ann Neurol.
  doi: 10.1002/ana.10483
– volume: 2
  start-page: a009399
  year: 2012
  ident: B7
  article-title: α-Synuclein in Parkinson's disease
  publication-title: Cold Spring Harb Perspect Med.
  doi: 10.1101/cshperspect.a009399
– volume: 140
  start-page: 831
  year: 2020
  ident: B25
  article-title: Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-020-02227-6
– volume: 22
  start-page: 2107
  year: 2015
  ident: B36
  article-title: Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2015.79
– volume: 24
  start-page: 197
  year: 2003
  ident: B47
  article-title: Staging of brain pathology related to sporadic Parkinson's disease
  publication-title: Neurobiol Aging.
  doi: 10.1016/S0197-4580(02)00065-9
– volume: 37
  start-page: 173
  year: 1991
  ident: B12
  article-title: A simple method for organotypic cultures of nervous tissue
  publication-title: J Neurosci Methods.
  doi: 10.1016/0165-0270(91)90128-M
– start-page: 55637
  year: 2017
  ident: B39
  article-title: Assessing autophagic flux by measuring LC3, p62, and LAMP1 co-localization using multispectral imaging flow cytometry
  publication-title: J Vis Exp.
  doi: 10.3791/55637
– volume: 8
  start-page: 2813
  year: 2018
  ident: B50
  article-title: Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice
  publication-title: Sci Rep.
  doi: 10.1038/s41598-018-21325-w
– volume: 15
  start-page: 203
  year: 2018
  ident: B33
  article-title: Ex vivo model of epilepsy in organotypic slices—a new tool for drug screening
  publication-title: J Neuroinflammation.
  doi: 10.1186/s12974-018-1225-2
– volume: 134
  start-page: 789
  year: 2017
  ident: B21
  article-title: α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-017-1746-2
– volume: 113
  start-page: E912
  year: 2016
  ident: B37
  article-title: Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease
  publication-title: Proc Nat Acad Sci USA.
  doi: 10.1073/pnas.1512876113
– volume: 2
  start-page: 88
  year: 2014
  ident: B28
  article-title: Pathological alpha-synuclein propagates through neural networks
  publication-title: Acta Neuropathol Commun.
  doi: 10.1186/s40478-014-0088-8
– volume: 2
  start-page: 16025
  year: 2016
  ident: B5
  article-title: Parkinson's disease as a system-level disorder
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/npjparkd.2016.25
– volume: 121
  start-page: 171
  year: 2014
  ident: B43
  article-title: A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease
  publication-title: J Neural Transm.
  doi: 10.1007/s00702-013-1084-z
– volume: 7
  start-page: 213
  year: 2019
  ident: B24
  article-title: Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
  publication-title: Acta Neuropathol Commun.
  doi: 10.1186/s40478-019-0865-5
– volume: 47
  start-page: 466
  year: 2013
  ident: B65
  article-title: α-Synuclein and neuronal cell death
  publication-title: Mol Neurobiol.
  doi: 10.1007/s12035-012-8327-0
– volume: 29
  start-page: 13578
  year: 2009
  ident: B48
  article-title: Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in -synuclein models of Parkinson's and Lewy body diseases
  publication-title: J Neurosci.
  doi: 10.1523/JNEUROSCI.4390-09.2009
– volume: 2016
  start-page: 5013409
  year: 2016
  ident: B32
  article-title: FBS or BSA inhibits EGCG induced cell death through covalent binding and the reduction of intracellular ROS production
  publication-title: Biomed Res Int.
  doi: 10.1155/2016/5013409
– volume: 7
  start-page: 279
  year: 2011
  ident: B51
  article-title: Selective autophagy mediated by autophagic adapter proteins
  publication-title: Autophagy.
  doi: 10.4161/auto.7.3.14487
– volume: 20
  start-page: 1069
  year: 2010
  ident: B30
  article-title: An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons
  publication-title: J Alzheimers Dis.
  doi: 10.3233/JAD-2010-091363
SSID ssj0000399363
Score 2.3009381
Snippet The accumulation of proteinaceous deposits comprised largely of the α-synuclein protein is one of the main hallmarks of Parkinson's disease (PD) and related...
The accumulation of proteinaceous deposits comprised largely of the alpha-synuclein protein is one of the main hallmarks of Parkinsons disease (PD) and related...
SourceID doaj
swepub
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 826102
SubjectTerms autophagy
Neurology
organotypic slice cultures
Parkinson's disease
PFF
α-synuclein
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHlZcEG_KY2UkBBJS2MSOXefYfWkFKpdl0d4s27HZSFVS0VSiB34Uf4TfxIydVhuB4MIxsZ04MxPPN358Q8gr6WsrrHJZcKLMSmZ5ZqraZ6JQ0yDqAlwcnh2ef5Tnl-X7K3F1I9UX7glL9MBJcIdVkFOjXMECMpvlylTg0OtclbyuTM0sjr7g824EU3EMRr8reVrGhCisOgzIDwnxIGPvAFEXwzTK1hFFvv4_gczf90qOGEWjFzq7S-4M8JHOUrfvkVu-vU_258MC-QPy_fTbssNJP9oF-vNHdrFpkbC4aensC0TWOGe2on1H4xHMrt8sG0cvFjBY0MStCaUAJM2y6TGtF1x98Bs636bQpQgYYyV4Op6XjkfH3qzoSVrmeUguz04_HZ9nQ4aFzImc95mXyvNQ2sIzQFp1JQyXARACyHsKvj0EG0oF8la1MYZXZfBOOMmCDzxAS8sfkb22a_0TQhk3PuAmG2lcyXJhg2MFdwAgIETK83pC8q24tRvoxzELxkJDGIIa0lFDGjWkk4Ym5O2uyTJxb_yt8hHqcFcRabPjDTAmPRiT_pcxTcjLrQVo-M1w7cS0vluvNODGAplyOLzocbKI3au44EjkByXTka2M-jIuaZvrSOUNwhVK8gl5naxq1OSk-TyL3V80a41ItlBP_8dXPiO3UXC497yQz8le_3XtXwC06u1B_It-ASGJJPg
  priority: 102
  providerName: Directory of Open Access Journals
Title Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/35309552
https://www.proquest.com/docview/2641509632
https://pubmed.ncbi.nlm.nih.gov/PMC8925863
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-183918
https://doaj.org/article/9f67a8c12f044408a9929d0843d9ad2b
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBelg7GXse9l3YoGYw8Dd9Zn5IcxsrWlbGQvXUbfjCxLrSHYaeJA87R_fXeyEzALY4-2JMu-k3y_k3S_I-Sd9mWhCuOS4JRMJC9EYrPSJ4qZcVAlAxOHscPTH_piJr9dqasDsk1v1Qtwtde1w3xSs-X85O528xkm_Cf0OMHefgxI_QiuHucnAJYZUkveA8M0xoQG0x7txx8zGuOYW41pLRNMZN3tc-5_ysBSRUL_fSj078OUA8rRaKbOH5GHPb6kk25APCYHvn5C7k_7HfSn5PfZ3aLBVUHaBBoDbZPLTY2kxlVNJ9fgfeO62oq2DY1hmk27WVSOXs7hh0I7_k0oBbBpF1WLqb_g6rvf0Ok2zS5FUBkrQQcYUx3Dy1b0tNsJekZm52c_v14kfRKGxKlUtInXxosgC-ZBXKzMlBU6AIgwDgTMZQhFkAYwlimttSKTwTvlNA8-iAAtC_GcHNZN7V8SyoX1Ac_haOskT1URHGfCAcYALypNyxFJtwLPXc9Qjoky5jl4KqijPOooRx3lnY5G5MOuyaKj5_hX5S-oxV1FZNaON5rldd5P1DwLemzh43hAJr3U2Aw-rkyNFGVmS16MyNvtGMhhJuL2iq19s17lAC0ZkukI6OhFNyZ2XQklkOsPSsaD0TJ4l2FJXd1Etm8QrjJajMj7blwNmpxWvybx9efVOkewy8yr_614RB6gcPAIOtOvyWG7XPs3gLDa4jiuTBzH2fMHLjYokw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exposure+of+alpha-Synuclein+Aggregates+to+Organotypic+Slice+Cultures+Recapitulates+Key+Molecular+Features+of+Parkinsons+Disease&rft.jtitle=Frontiers+in+neurology&rft.au=Moudio%2C+Serge&rft.au=Rodin%2C+Fredrik&rft.au=Albargothy%2C+Nazira&rft.au=Karlsson%2C+Urban&rft.date=2022-02-16&rft.issn=1664-2295&rft.eissn=1664-2295&rft.volume=13&rft_id=info:doi/10.3389%2Ffneur.2022.826102&rft.externalDocID=oai_DiVA_org_liu_183918
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2295&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2295&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2295&client=summon